Cel Sci (CVM) Treasury Shares (2020 - 2025)
Cel Sci (CVM) posted Treasury Shares of $319111.0 for Q3 2025, up 39.6% sequentially from $228593.0 in Q3 2024, and up 39.6% YoY from $228593.0 in Q3 2024.
Cel Sci (CVM) Treasury Shares (2020 - 2025) Analysis & Trends
Cel Sci has reported Treasury Shares for 6 years, with the latest figure at $319111.0 in Q3 2025.
- Quarterly Treasury Shares rose 39.6% year-over-year to $319111.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $319111.0 (up 39.6% YoY) and the FY2025 annual result came in at $319111.0, up 39.6% from the prior year.
- Treasury Shares grew to $319111.0 in Q3 2025 per CVM's latest filing, from $228593.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $5.9 million in Q3 2022 and troughed at $226557.0 in Q3 2023.
- A 5-year average of $2.4 million and a median of $319111.0 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2023: Treasury Shares soared 5274.2% in 2021, then plunged 96.16% in 2023.
- Over 5 years, Treasury Shares stood at $5.5 million in 2021, then increased by 7.02% to $5.9 million in 2022, then slumped by 96.16% to $226557.0 in 2023, then advanced by 0.9% to $228593.0 in 2024, then jumped by 39.6% to $319111.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $319111.0, $228593.0, and $226557.0 for Q3 2025, Q3 2024, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 2.72 Mn |
| 10 | Cel Sci | 2.13 Mn | -4.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 319,111.00 |
| Sep 30, 2025 | 319,111.00 |
| Sep 30, 2024 | 228,593.00 |
| Sep 30, 2024 | 228,593.00 |
| Sep 30, 2023 | 226,557.00 |
| Sep 30, 2023 | 226,557.00 |
| Sep 30, 2022 | 5.90 Mn |
| Sep 30, 2022 | 5.90 Mn |
| Sep 30, 2021 | 5.51 Mn |
| Sep 30, 2021 | 5.51 Mn |
| Dec 31, 2020 | 93,521.00 |
| Dec 31, 2020 | 93,521.00 |
| Sep 30, 2020 | 102,521.00 |
| Sep 30, 2020 | 102,521.00 |
| Jun 30, 2020 | 110,521.00 |
| Jun 30, 2020 | 110,521.00 |